← TrialMatch
HomeTrials

Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Che

The purpose of this study was to investigate the role of immunonutrion compared with standard nutrition in reducing oral mucositis in patients with locally advanced nasopharyngeal carcinoma.

Condition(s)Locally Advanced Nasopharyngeal Carcinoma
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThe purpose of this study was to investigate the role of immunonutrion compared with standard nutrition in reducing oral mucositis in patients with locally advanced nasopharyngeal carcinoma.
Who can participateInclusion Criteria: 1. Eastern Cooperative Oncology Group (ECOG) performance status 0-1; 2. Age 18-70 years old, male or non-pregnant women; 3. Pathologically confirmed non-keratinizing carcinoma of the nasopharynx (differentiated or undifferentiated,WHO type II or III); 4. Newly diagnosed stage III-IVa (8th AJCC/UICC stage) NPC patients; 5. The levels of major organ function meet the following criteria: (1)Hematology: WBC ≥ 3.0 × 10\^9/L, ANC ≥ 1.5 × 10\^9/L, PLT ≥ 100 × 10\^9/L, HGB ≥ 90 g/L; (2) Liver function: ALT, AST≤2.5 times the upper limit of normal (ULN), total bilirubin ≤ 1.5 × ULN; (3) Renal function: BUN and CRE ≤ 1.5 × ULN or an estimated glomerular filtration rate (eGFR) ≥ 60 ml/min (calculated using the Cockcroft-Gault equation); (4) Adequate coagulation function: defined a
Ages18 Years to 70 Years
SexAll
Lead sponsorFirst Affiliated Hospital of Guangxi Medical University
LocationsFuzhou, Fujian, China; Fuzhou, Fujian, China; Guangzhou, Guangdong, China; Guangzhou, Guangdong, China; Huizhou, Guangdong, China; Guilin, Guangxi, China (+14 more sites)
Start date2023-06-12
NCT IDNCT05892354
Official listinghttps://clinicaltrials.gov/study/NCT05892354

🔍 Search all trials →